Literature DB >> 17513569

Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?

Georg Schett, Robert Landewé, Désirée van der Heijde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17513569      PMCID： PMC1954668          DOI： 10.1136/ard.2007.071159

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  22 in total

1.  Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton.

Authors:  C Hartmann; C J Tabin
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

2.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Authors:  Lars Klareskog; Désirée van der Heijde; Julien P de Jager; Andrew Gough; Joachim Kalden; Michel Malaise; Emilio Martín Mola; Karel Pavelka; Jacques Sany; Lucas Settas; Joseph Wajdula; Ronald Pedersen; Saeed Fatenejad; Marie Sanda
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

4.  Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.

Authors:  M Boers; P J Kostense; A C Verhoeven; S van der Linden
Journal:  Arthritis Rheum       Date:  2001-10

5.  Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.

Authors:  Kurt Redlich; Silvia Hayer; Andrea Maier; Colin R Dunstan; Makiyeh Tohidast-Akrad; Susanne Lang; Birgit Türk; Peter Pietschmann; Wolfgang Woloszczuk; Silva Haralambous; George Kollias; Günter Steiner; Josef S Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2002-03

6.  Expression of osteoclast differentiation factor in rheumatoid arthritis.

Authors:  Y Shigeyama; T Pap; P Kunzler; B R Simmen; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  2000-11

7.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.

Authors:  Alwin Scharstuhl; Elly L Vitters; Peter M van der Kraan; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2003-12

9.  Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

Authors:  Walter P Maksymowych; Robert Landewé; Barbara Conner-Spady; Maxime Dougados; Herman Mielants; Hille van der Tempel; A Robin Poole; Nandi Wang; Désirée van der Heijde
Journal:  Arthritis Rheum       Date:  2007-06

10.  Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

Authors:  John C Davis; Désirée Van Der Heijde; Jurgen Braun; Maxime Dougados; John Cush; Daniel O Clegg; Alan Kivitz; Roy Fleischmann; Robert Inman; Wayne Tsuji
Journal:  Arthritis Rheum       Date:  2003-11
View more
  12 in total

1.  Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.

Authors:  Seong-Ryul Kwon; Mie-Jin Lim; Chang-Hee Suh; Shin-Goo Park; Yeon-Sik Hong; Bo-Young Yoon; Hyoun-Ah Kim; Hyo-Jin Choi; Won Park
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 2.  Joint remodelling in inflammatory disease.

Authors:  Georg Schett
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

3.  Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis.

Authors:  Leonie M van Duivenvoorde; Martha L Dorris; Nimman Satumtira; Melissa N van Tok; Kurt Redlich; Paul P Tak; Joel D Taurog; Dominique L Baeten
Journal:  Arthritis Rheum       Date:  2012-10

Review 4.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

Review 5.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

6.  [New aspects in the area of spondyloarthritis. Report on the 6(th) International Congress on Spondyloarthropathies].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

Review 7.  The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2019-09-24       Impact factor: 20.543

8.  The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.

Authors:  Xenofon Baraliakos; Joachim Listing; Martin Rudwaleit; Joachim Sieper; Juergen Braun
Journal:  Arthritis Res Ther       Date:  2008-09-01       Impact factor: 5.156

9.  Evaluation of destruction in a collagen-induced arthritis rat model: Bony spur formation.

Authors:  Yiping Hu; Yi Yang; Bin Luo
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

10.  The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGFβ Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A.

Authors:  Iwona Adwent; Beniamin Oskar Grabarek; Marta Kojs-Mrożkiewicz; Ryszard Brus; Rafał Staszkiewicz; Andrzej Plewka; Michał Stasiowski; Anita Lyssek-Boroń
Journal:  Mediators Inflamm       Date:  2020-07-26       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.